These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16396244

  • 1. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
    Wozniak KL, Palmer G, Kutner R, Fidel PL.
    Med Mycol; 2005 Nov; 43(7):589-601. PubMed ID: 16396244
    [Abstract] [Full Text] [Related]

  • 2. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.
    Taylor BN, Saavedra M, Fidel PL.
    Med Mycol; 2000 Dec; 38(6):419-31. PubMed ID: 11204879
    [Abstract] [Full Text] [Related]

  • 3. Candida-specific antibodies during experimental vaginal candidiasis in mice.
    Wozniak KL, Wormley FL, Fidel PL.
    Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
    [Abstract] [Full Text] [Related]

  • 4. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection.
    Wormley FL, Cutright J, Fidel PL.
    Med Mycol; 2003 Oct; 41(5):401-9. PubMed ID: 14653516
    [Abstract] [Full Text] [Related]

  • 5. Immunity to Candida.
    Fidel PL.
    Oral Dis; 2002 Oct; 8 Suppl 2():69-75. PubMed ID: 12164664
    [Abstract] [Full Text] [Related]

  • 6. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
    Fidel PL, Lynch ME, Sobel JD.
    Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
    [Abstract] [Full Text] [Related]

  • 7. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.
    Fidel PL, Lynch ME, Sobel JD.
    Infect Immun; 1994 Mar; 62(3):1032-8. PubMed ID: 8112837
    [Abstract] [Full Text] [Related]

  • 8. Immunopathogenesis of recurrent vulvovaginal candidiasis.
    Fidel PL, Sobel JD.
    Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
    [Abstract] [Full Text] [Related]

  • 9. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.
    Fidel PL, Lynch ME, Sobel JD.
    Infect Immun; 1995 Jul; 63(7):2403-8. PubMed ID: 7790050
    [Abstract] [Full Text] [Related]

  • 10. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
    Fidel PL, Lynch ME, Sobel JD.
    Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493
    [Abstract] [Full Text] [Related]

  • 11. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
    Fidel PL, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD.
    J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
    [Abstract] [Full Text] [Related]

  • 12. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
    Fidel PL, Lynch ME, Conaway DH, Tait L, Sobel JD.
    Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
    [Abstract] [Full Text] [Related]

  • 13. Local production of chemokines during experimental vaginal candidiasis.
    Saavedra M, Taylor B, Lukacs N, Fidel PL.
    Infect Immun; 1999 Nov; 67(11):5820-6. PubMed ID: 10531235
    [Abstract] [Full Text] [Related]

  • 14. New immunotherapeutic strategies to control vaginal candidiasis.
    Magliani W, Conti S, Cassone A, De Bernardis F, Polonelli L.
    Trends Mol Med; 2002 Mar; 8(3):121-6. PubMed ID: 11879772
    [Abstract] [Full Text] [Related]

  • 15. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
    Fidel PL.
    Int Rev Immunol; 2002 Mar; 21(6):515-48. PubMed ID: 12650240
    [Abstract] [Full Text] [Related]

  • 16. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.
    Wormley FL, Chaiban J, Fidel PL.
    Infect Immun; 2001 Aug; 69(8):5072-9. PubMed ID: 11447188
    [Abstract] [Full Text] [Related]

  • 17. Role for dendritic cells in immunoregulation during experimental vaginal candidiasis.
    LeBlanc DM, Barousse MM, Fidel PL.
    Infect Immun; 2006 Jun; 74(6):3213-21. PubMed ID: 16714548
    [Abstract] [Full Text] [Related]

  • 18. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X, Li T, Chen X, Wang S, Liu Z.
    BMC Microbiol; 2018 Oct 25; 18(1):166. PubMed ID: 30359236
    [Abstract] [Full Text] [Related]

  • 19. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection.
    Kelly KA, Gray HL, Walker JC, Rank RG, Wormley FL, Fidel PL.
    Infect Immun; 2001 May 25; 69(5):3451-4. PubMed ID: 11292774
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.
    De Bernardis F, Lucciarini R, Boccanera M, Amantini C, Arancia S, Morrone S, Mosca M, Cassone A, Santoni G.
    Infect Immun; 2006 Jul 25; 74(7):4282-94. PubMed ID: 16790803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.